Xcelerated Profits Report

Average Subscriber Review:

Monthly newsletter with stock and option trade recommendations.

Print this article | Email this article

Posted in Options or Futures, Stocks |

Gumshoe Articles & Teaser Picks Revealed

“Tiny Biotech Unveils ‘Single Shot’ Cure for Heart Disease”

“Tulane University Confirms Medical Breakthrough: “Tiny Biotech Unveils ‘Single Shot’ Cure for Heart Disease “The news could go public any day… and this small San Diego-based company will instantly dominate a $305 BILLION market. “Investors who act now could book gains of 9,275%… “ Now THAT’S what I want to hear — looking at gold [...]

20 Comments Read More »

Pocket Nine-times your money with HCIT: “This Discreet Amsterdam ‘Rendezvous’ Will Ignite a $678 Billion Tech Explosion”

One of the fun things about serving as your friendly neighborhood Stock Gumshoe is that boredom is never a challenge — each morning I get up and check the email box, and there’s invariably some bit of balderdash in there just waiting for a look-see. And today? No different, as you’ve no doubt surmised. Today [...]

8 Comments Read More »

“How to Collect $30,000 to $250,000 in ‘Unclaimed Inheritance Money’ “

That sounds pretty good, right? It’s everyone’s dream, a rich great-uncle that you never knew, and years later you find out that you were left a fortune in his will, and he’s been dead for years and a banker’s knocking at the door trying to give you a bag full of Krugerrands. Ah, those are [...]

7 Comments Read More »

“Photon Beam Technology Kills Cancer in 16 Minutes”

This ad has been crashing in on Gumshoe beach in massive waves over the last week, so I thought it might be time to take a gander. It’s for the Xcelerated Profits report at Mt. Vernon Research — the last time I saw a similar ad it was from Karim Rahemtulla for this same report, [...]

66 Comments Read More »

Closing out “Capone’s Legacy” … Cigars, Cigarettes, Slot Machines?

I’ve probably thrown out more chatter than anyone can tolerate about Al Capone and sin stocks, so maybe now we should just go through the three remaining “sin stock” teasers, in businesslike fashion, with a minimum of interruptions … Capone’s Legacy Stock #4 from Karim Rahemtulla … “How to Book 548% From the Slots” “This [...]

11 Comments Read More »

Subscriber Reviews

Posted by Myron Martin on Aug 18, 2009 @ 3:57 pm

i subscribed for 2 years, I think for $49.50 per year if I recall correctly but finally let the subscription lapse simply because I had too many newsletters to keep up with them all and too little capital to take advantage of even a small percentage of the recommendations.

Like most newsletters, (in my experience) the substance was far less than the hype but the deciding factor for me was that most recommendations seemed to be drug related and I simply have no interest in pharmaceuticals which I consider more harmful than helpful. Simply stating my bias, for someone, who wants to follow drug companies it is probably as good as any in this field, just not my cup of tea.

Overall Rating
Performance of Picks/Advice
Consistency	Not Rated
Interesting to Read/Educational
Customer Service
Value for the Money

submit a review of Xcelerated Profits Report Cancel reply

Your email address will not be published.

Name *

Email *

Website

Overall Rating
Performance of Picks/Advice
Consistency
Interesting to Read/Educational
Customer Service
Value for the Money

Review

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>